Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$108.81 - $179.33 $354,394 - $584,077
-3,257 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$119.61 - $157.85 $4.29 Million - $5.66 Million
-35,867 Reduced 91.68%
3,257 $469,000
Q4 2021

Feb 14, 2022

BUY
$142.57 - $190.86 $4.54 Million - $6.07 Million
31,817 Added 435.43%
39,124 $6.05 Million
Q2 2021

Aug 16, 2021

SELL
$135.08 - $161.1 $4.01 Million - $4.79 Million
-29,704 Reduced 80.26%
7,307 $1.15 Million
Q1 2021

May 17, 2021

BUY
$137.51 - $190.8 $5.09 Million - $7.06 Million
37,011 New
37,011 $5.14 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.